Steven Cohen's NVO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 29,198 shares of Novo Nordisk A/S (NVO) worth $1.4 M, representing 0.00% of the portfolio. First purchased in 2014-Q4, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in NVO, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2018, adding 1.78 M shares. Largest reduction occurred in Q2 2019, reducing 1.66 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Novo Nordisk A/S (NVO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Novo Nordisk A/S (NVO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +29,198 | New Buy | 29,198 | $47.94 |
| Q3 2024 | -960,854 | Sold Out | 0 | $0.00 |
| Q2 2024 | +960,854 | New Buy | 960,854 | $142.74 |
| Q3 2023 | -134 | Sold Out | 0 | $0.00 |
| Q2 2023 | +134 | New Buy | 134 | $80.92 |
| Q3 2022 | -52,540 | Sold Out | 0 | $0.00 |
| Q2 2022 | -1.12 M | Reduce 95.51% | 52,540 | $55.71 |
| Q1 2022 | +1.17 M | New Buy | 1.17 M | $55.52 |
| Q1 2020 | -117,240 | Sold Out | 0 | $0.00 |
| Q4 2019 | +117,240 | New Buy | 117,240 | $28.94 |
| Q2 2019 | -1.66 M | Sold Out | 0 | $0.00 |
| Q1 2019 | -120,204 | Reduce 6.74% | 1.66 M | $26.15 |
| Q4 2018 | +1.78 M | New Buy | 1.78 M | $23.04 |
| Q1 2018 | -591,726 | Sold Out | 0 | $0.00 |
| Q4 2017 | +292,926 | Add 98.03% | 591,726 | $26.84 |
| Q3 2017 | +298,800 | New Buy | 298,800 | $24.08 |
| Q1 2015 | -963,400 | Sold Out | 0 | $0.00 |
| Q4 2014 | +963,400 | New Buy | 963,400 | $21.16 |
Steven Cohen's Novo Nordisk A/S Investment FAQs
Steven Cohen first purchased Novo Nordisk A/S (NVO) in Q4 2014, acquiring 963,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Novo Nordisk A/S (NVO) for 18 quarters since Q4 2014.
Steven Cohen's largest addition to Novo Nordisk A/S (NVO) was in Q4 2018, adding 1,782,412 shares worth $41.06 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 29,198 shares of Novo Nordisk A/S (NVO), valued at approximately $1.4 M.
As of the Q2 2026 filing, Novo Nordisk A/S (NVO) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Novo Nordisk A/S (NVO) was 1,782,412 shares, as reported at the end of Q4 2018.